Research record: Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings.
Published in Arch Bronconeumol; first publication date 2026-04-24. PMID 42135169.
This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.